Skip to search formSkip to main contentSkip to account menu

MK-0366

Known as: MK 366, MK 0366, MK366 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Norfloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715)
Norfloxacin is a new orally absorbed quinoline derivative structurally related to nalidixic acid but showing an expanded… 
Highly Cited
1983
Highly Cited
1983
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens
A comparison was made of the in vitro activities of norfloxacin and of nine other orally administered antibacterial agents… 
1983
1983
Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients.
Norfloxacin (MK-0366) is a new antibacterial agent, closely related to nalidixic acid, with broad spectrum activity against Gram… 
1983
1983
The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
Norfloxacin (MK0366) displayed appreciable activity against the great majority of Gram-negative and Gram-positive bacteria. The… 
1983
1983
Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains
We compared the activity of norfloxacin (MK-0366), a new orally absorbable derivative of naladixic acid, with those of other… 
Highly Cited
1982
Highly Cited
1982
In vitro antibacterial activity of norfloxacin (MK-0366)
The in vitro activity of norfloxacin (MK-0366) compared with that of beta-lactam antibiotics and, where appropriate of gentamicin… 
1982
1982
In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa
MK-0366, a new derivative of nalidixic acid, was tested against 250 urinary pathogens including Escherichia coli, Serratia… 
Highly Cited
1982
Highly Cited
1982
Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography
A high-performance liquid chromatographic method for the analysis of norfloxacin (MK-366) [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7… 
Highly Cited
1982
Highly Cited
1982
Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates
The in vitro activity of a new oral antimicrobial agent, norfloxacin (MK-0366), was compared with those of nalidixic acid… 
1981
1981
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae
The in vitro activity of a new ora antimicrobial agent, Mk-0366 (AM-715), was compared with those of rosoxacin, ampicillin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License